Rimonabant (Acomplia): The first cannabinoid-I receptor blocker for obesity

Research output: Contribution to journal › Review article › peer-review

ASJC Scopus Subject Areas

@article{010c63fc58a44815943759a2967142f3,

title = "Rimonabant (Acomplia): The first cannabinoid-I receptor blocker for obesity",

author = "Luque, \{Carta A.\} and Ehret, \{Megan J.\} and Rey, \{Jose A.\}",

year = "2007",

month = apr,

language = "English",

volume = "32",

pages = "209--213+234",

journal = "P and T",

issn = "1052-1372",

number = "4",

}

TY - JOUR

T1 - Rimonabant (Acomplia)

T2 - The first cannabinoid-I receptor blocker for obesity

AU - Luque, Carta A.

AU - Ehret, Megan J.

AU - Rey, Jose A.

PY - 2007/4

Y1 - 2007/4

UR - https://www.scopus.com/pages/publications/34248346324

UR - https://www.scopus.com/pages/publications/34248346324#tab=citedBy

M3 - Review article

AN - SCOPUS:34248346324

SN - 1052-1372

VL - 32

SP - 209-213+234

JO - P and T

JF - P and T

IS - 4

ER -